tiprankstipranks
Trending News
More News >
Shanghai Kindly Medical Instruments Co., Ltd. Class H (HK:1501)
:1501
Hong Kong Market

Shanghai Kindly Medical Instruments Co., Ltd. Class H (1501) Price & Analysis

Compare
1 Followers

1501 Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.13%99.85%
Insiders
0.13%
Mutual Funds
― Other Institutional Investors
99.85% Public Companies and
Individual Investors

1501 FAQ

What was Shanghai Kindly Medical Instruments Co., Ltd. Class H’s price range in the past 12 months?
Shanghai Kindly Medical Instruments Co., Ltd. Class H lowest stock price was HK$25.00 and its highest was HK$32.00 in the past 12 months.
    What is Shanghai Kindly Medical Instruments Co., Ltd. Class H’s market cap?
    Shanghai Kindly Medical Instruments Co., Ltd. Class H’s market cap is HK$4.48B.
      When is Shanghai Kindly Medical Instruments Co., Ltd. Class H’s upcoming earnings report date?
      Shanghai Kindly Medical Instruments Co., Ltd. Class H’s upcoming earnings report date is Aug 15, 2025 which is in 81 days.
        How were Shanghai Kindly Medical Instruments Co., Ltd. Class H’s earnings last quarter?
        Shanghai Kindly Medical Instruments Co., Ltd. Class H released its earnings results on Mar 18, 2025. The company reported HK$0.569 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.569.
          Is Shanghai Kindly Medical Instruments Co., Ltd. Class H overvalued?
          According to Wall Street analysts Shanghai Kindly Medical Instruments Co., Ltd. Class H’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Shanghai Kindly Medical Instruments Co., Ltd. Class H pay dividends?
            Shanghai Kindly Medical Instruments Co., Ltd. Class H pays a Annually dividend of HK$0.3 which represents an annual dividend yield of 1.18%. See more information on Shanghai Kindly Medical Instruments Co., Ltd. Class H dividends here
              What is Shanghai Kindly Medical Instruments Co., Ltd. Class H’s EPS estimate?
              Shanghai Kindly Medical Instruments Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Shanghai Kindly Medical Instruments Co., Ltd. Class H have?
              Shanghai Kindly Medical Instruments Co., Ltd. Class H has 104,213,394 shares outstanding.
                What happened to Shanghai Kindly Medical Instruments Co., Ltd. Class H’s price movement after its last earnings report?
                Shanghai Kindly Medical Instruments Co., Ltd. Class H reported an EPS of HK$0.569 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.184%.
                  Which hedge fund is a major shareholder of Shanghai Kindly Medical Instruments Co., Ltd. Class H?
                  Currently, no hedge funds are holding shares in HK:1501

                  Shanghai Kindly Medical Instruments Co., Ltd. Class H Stock Smart Score

                  Company Description

                  Shanghai Kindly Medical Instruments Co., Ltd. Class H

                  Shanghai Kindly Medical Instruments Co., Ltd. engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. The company offers interventions products, which includes guiding catheter used to provide a channel for introducing balloon catheter, guidewire or other treatment devices; micro catheter to support the placement of guide wires; guidewire used in percutaneous transluminal angioplasty (PTA) surgical procedures; angiography catheter used to inject and infuse contrast media and fluid; and Y-connector pack used in PTCA surgery. It also provides inflation device used to inflate the balloon of dilating the vessel or placing the stent in the vessel; manifold for single use; manifold kit; pressure bandage used to assist compression hemostasis; angiography syringe for single use; stopcocks used for pressure monitoring tubing during surgery; sterile seldinger needle used to puncture into the artery; introducer set; pressure transducer for single use; extension tube for pressure monitoring; and introducer tool kit used in percutaneous vertebroplasty. In addition, the company offers medical accessories, such as check value, needle free connector, male Luer locks, bi-stopper, Heparian cap, flush device, and flow regulator; other products, including joint intervention kit, disposable respirator masks, vaginal dilator used during a vaginal examination, foley catheter, infusion pumps, disposable automatic umbilical cord clamps, infusion connector and accessory for single use, and burette infusion sets without a needle. It serves medical device manufacturers and other customers. The company was founded in 2006 and is headquartered in Shanghai, China. Shanghai Kindly Medical Instruments Co., Ltd. is a subsidiary of Shanghai Kindly Enterprise Development Group Co., Ltd.

                  1501 Stock 12 Month Forecast

                  Average Price Target

                  HK$33.68
                  ▲( 32.34% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"24":"HK$24","29":"HK$29","34":"HK$34","26.5":"HK$26.5","31.5":"HK$31.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":33.68,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$33.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":33.68,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$33.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":33.68,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$33.68</span>\n  </div></div>","useHTML":true}}],"tickPositions":[24,26.5,29,31.5,34],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2023","6":"May<br/>2023","9":"Aug<br/>2023","12":"Mar<br/>2025","25":"Mar<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28,28.436923076923076,28.873846153846152,29.310769230769232,29.747692307692308,30.184615384615384,30.62153846153846,31.05846153846154,31.495384615384616,31.932307692307692,32.36923076923077,32.80615384615385,33.24307692307692,{"y":33.68,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28,28.436923076923076,28.873846153846152,29.310769230769232,29.747692307692308,30.184615384615384,30.62153846153846,31.05846153846154,31.495384615384616,31.932307692307692,32.36923076923077,32.80615384615385,33.24307692307692,{"y":33.68,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28,28.436923076923076,28.873846153846152,29.310769230769232,29.747692307692308,30.184615384615384,30.62153846153846,31.05846153846154,31.495384615384616,31.932307692307692,32.36923076923077,32.80615384615385,33.24307692307692,{"y":33.68,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":26.24,"date":1667260800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.4,"date":1669852800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.15,"date":1672531200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.56,"date":1675209600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.83,"date":1677628800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.8,"date":1680307200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.35,"date":1682899200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.15,"date":1685577600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.52,"date":1688169600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.7,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.7,"date":1690848000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.45,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Livzon Pharmaceutical Group
                  Suncity Group Holdings
                  Sinopharm Group Co
                  Shandong Weigao Group Medical Polymer Co
                  China Sanjiang Fine Chemicals Co., Ltd.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis